NEWS & EVENTS

PRESENTATIONS

January 11, 2012

Biotech Showcase 2012
January 11, 2012 at 10:00 a.m.

Parc 55 Wyndham Hotel, San Francisco

 

view Biotech Showcase Web site

 

 

October 26, 2011

10th Annual Bio Investor Forum
October 26, 2011 at 9:30 a.m.

Palace Hotel in San Francisco

Subject: Company overview and update on anthim development progress

 

view Bio Investor Forum Web site

 

 

May 16, 2010

AAPS National Biotechnology Conference

Immunogenicity Assessment of Humanized Deimmunized Therapeutic Monoclonal Antibody ETI-204 (Anthim®) in a Phase I Clinical Study with a Validated Electrochemiluminescence Immunoassay

 

click to view pdf

 

 

April 30, 2009

Bacillus ACT 2009

ETI-204 Anti-Toxin Monoclonal Antibody Treatment of Active Anthrax Disease in Rabbits

 

click to view pdf


 

May 9, 2008

ICAAC 2008 Anthim
ETI-204 Provides a Dramatic Improvement in Survival at the Onset of Active Anthrax Disease and is Well Tolerated in Nonhuman Primates

 

click to view pdf